173 related articles for article (PubMed ID: 29037941)
1. Pre-clinical assessment of the Lovo device for dimethyl sulfoxide removal and cell concentration in thawed hematopoietic progenitor cell grafts.
Mfarrej B; Bouchet G; Couquiaud J; Regimbaud L; Binninger S; Mercier M; Lemarié C; Houzé P; Chabannon C; Calmels B
Cytotherapy; 2017 Dec; 19(12):1501-1508. PubMed ID: 29037941
[TBL] [Abstract][Full Text] [Related]
2. Study of a new device for washing and concentrating cryopreserved hematopoietic stem cells and mononuclear cells: a single center experience.
Santurette CC; Charron M; Bouyer S; Houzé P; Binninger S; Lavergne A; Mercier M; Giraud C
Cytotherapy; 2022 Jan; 24(1):86-92. PubMed ID: 34690062
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing.
Rodríguez L; Velasco B; García J; Martín-Henao GA
Transfusion; 2005 Aug; 45(8):1391-7. PubMed ID: 16078930
[TBL] [Abstract][Full Text] [Related]
4. Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells.
Mfarrej B; Vicari O; Ouffai S; Malenfant C; Granata A; Thevenet S; Chabannon C; Lemarié C; Calmels B
J Transl Med; 2022 Nov; 20(1):503. PubMed ID: 36329460
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing.
Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C
Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892
[TBL] [Abstract][Full Text] [Related]
6. Automatic washing of thawed haematopoietic progenitor cell grafts: a preclinical evaluation.
Abonnenc M; Pesse B; Tissot JD; Barelli S; Lion N
Vox Sang; 2017 May; 112(4):367-378. PubMed ID: 28337763
[TBL] [Abstract][Full Text] [Related]
7. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
[TBL] [Abstract][Full Text] [Related]
8. Pentaisomaltose, an Alternative to DMSO. Engraftment of Cryopreserved Human CD34
Svalgaard JD; Talkhoncheh MS; Haastrup EK; Munthe-Fog L; Clausen C; Hansen MB; Andersen P; Gørløv JS; Larsson J; Fischer-Nielsen A
Cell Transplant; 2018 Sep; 27(9):1407-1412. PubMed ID: 30056762
[TBL] [Abstract][Full Text] [Related]
9. Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood.
Yang H; Zhao H; Acker JP; Liu JZ; Akabutu J; McGann LE
Cryobiology; 2005 Oct; 51(2):165-75. PubMed ID: 16111670
[TBL] [Abstract][Full Text] [Related]
10. Cryopreservation of hematopoietic cells using a pre-constituted, protein-free cryopreservative solution with 5% dimethyl sulfoxide.
Trummer T; Fox R; Koç JR; de Lima M; Otegbeye F
Cytotherapy; 2020 Nov; 22(11):613-616. PubMed ID: 32600975
[TBL] [Abstract][Full Text] [Related]
11. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
[TBL] [Abstract][Full Text] [Related]
12. Washing transplants with Sepax 2 reduces the incidence of side effects associated with autologous transplantation and increases patients' comfort.
Huvarová L; Kořístek Z; Jelínek T; Černá L; Smejkalová J; Navrátil M; Grebeníček L; Tvrdá I; Michalíková M; Hájek R
Transfusion; 2021 Aug; 61(8):2430-2438. PubMed ID: 34197635
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of cryopreservation on clinically prepared hematopoietic progenitor cell products.
Winter JM; Jacobson P; Bullough B; Christensen AP; Boyer M; Reems JA
Cytotherapy; 2014 Jul; 16(7):965-75. PubMed ID: 24910385
[TBL] [Abstract][Full Text] [Related]
14. Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells.
Smagur A; Mitrus I; Giebel S; Sadus-Wojciechowska M; Najda J; Kruzel T; Czerw T; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Holowiecki J
Vox Sang; 2013 Apr; 104(3):240-7. PubMed ID: 23046417
[TBL] [Abstract][Full Text] [Related]
15. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
16. Post-thaw viability of cryopreserved hematopoietic progenitor cell grafts: does it matter?
Vrhovac R; Perić Z; Jurenec S; Kardum-Skelin I; Jelić-Puskarić B; Jaksić B
Coll Antropol; 2010 Mar; 34(1):163-9. PubMed ID: 20432746
[TBL] [Abstract][Full Text] [Related]
17. The value of the post-thaw CD34+ count with and without DMSO removal in the setting of autologous stem cell transplantation.
Rohner N; Passweg JR; Tsakiris DA; Halter JP; Heim D; Buser AS; Infanti L; Holbro A
Transfusion; 2019 Mar; 59(3):1052-1060. PubMed ID: 30556582
[TBL] [Abstract][Full Text] [Related]
18. Effects of extended transport on cryopreserved allogeneic hematopoietic progenitor cell (HPC) product quality and optimal methods to assess HPC stability.
Reddy OL; Sall MT; Dinh A; Cai Y; Ongkeko M; Arya N; Wilder J; Tran M; Jin P; Stroncek DF; Panch SR
Transfusion; 2023 Apr; 63(4):774-781. PubMed ID: 36975826
[TBL] [Abstract][Full Text] [Related]
19. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate.
Lemarie C; Calmels B; Malenfant C; Arneodo V; Blaise D; Viret F; Bouabdallah R; Ladaique P; Viens P; Chabannon C
Transfusion; 2005 May; 45(5):737-42. PubMed ID: 15847663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]